UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 12, 2019

BABCOCK & WILCOX ENTERPRISES, INC.
(Exact name of registrant as specified in its charter)

DELAWARE
001-36876
47-2783641
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
20 SOUTH VAN BUREN AVENUE BARBERTON, OHIO
44203
(Address of principal executive offices)
(Zip Code)
Registrant’s Telephone Number, including Area Code:  (330) 753-4511

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.01 par value
BW
New York Stock Exchange






Item 8.01 Other Events

Babcock & Wilcox Enterprises, Inc. (the "Company") previously disclosed in our Quarterly Reports for the period ended March 31, 2019 filed on May 9, 2019 and for the period ended June 30, 2019 filed on August 8, 2019 that we reached an agreement in principle with plaintiffs' counsel to resolve (a) three separate but substantially similar derivative lawsuits naming the Company and certain of its present and former officers and directors as defendants and which have been consolidated and are pending in the United States District Court for the Western District of North Carolina (the "Federal Court Derivative Litigation"), (b) an additional shareholder derivative lawsuit naming the Company and certain of its present and former officers and directors as defendants and which is pending in the North Carolina Superior Court (the "State Court Derivative Litigation"), and (c) a consolidated lawsuit alleging violations of federal securities law brought on behalf of a class of investors who purchased the Company's common stock and naming the Company and certain of its former officers and directors which suit was filed in the United States District Court for the Western District of North Carolina (the "Stockholder Litigation").

The parties to the Federal Court Derivative Litigation and the State Court Derivative Litigation executed a Stipulation and Agreement of Settlement (the "Federal Court Derivative Litigation and the State Court Derivative Litigation Settlement Agreement") on July 22, 2019. The Federal Court Derivative Litigation and the State Court Derivative Litigation Settlement Agreement was filed with the United States District Court for the Western District of North Carolina on August 2, 2019 and preliminarily approved by that Court on August 12, 2019. A copy of the Summary Notice of Proposed Settlement is attached as Exhibit 99.1. A copy of the Federal Court Derivative Litigation and the State Court Derivative Litigation Settlement Agreement and related Notice of Proposed Settlement can be viewed and downloaded from the Company's website at www.babcock.com/questions.

The parties to the Stockholder Litigation executed a Stipulation and Agreement of Settlement (the "Stockholder Litigation Settlement Agreement") on June 21, 2019.   The Stockholder Litigation Settlement Agreement was filed with the United States District Court for the Western District of North Carolina on June 25, 2019 and preliminarily approved by that Court on August 12, 2019.

The information furnished pursuant to this Item 8.01, including Exhibit 99.1 furnished hereto, shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01.    Financial Statements and Exhibits

(d) Exhibits
Exhibit No.
 
Description
 
Summary Notice of Proposed Settlement of Federal and State Court Derivative Litigation






Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
BABCOCK & WILCOX ENTERPRISES, INC.
 
 
 
 
 
August 15, 2019
By:
/s/ Robert P. McKinney
 
 
Robert P. McKinney
 
 
Senior Vice President, General Counsel and Corporate Secretary





Exhibit 99.1



IN THE UNITED STATES DISTRICT COURT
FOR THE WESTERN DISTRICT OF NORTH CAROLINA
CHARLOTTE DIVISION
Lead No. 3:18-cv-00347-MOC-DCK
(Consolidated with Nos. 3:18-cv-00349-MOC-DCK and 3:18-cv-00350-MOC-DCK)


IN RE BABCOCK & WILCOX ENTERPRISES, INC. SHAREHOLDER DERIVATIVE LITIGATION


This Document Relates to:

             ALL ACTIONS.

)
)
)
)
)
)
)
)
)



SUMMARY NOTICE OF PROPOSED SETTLEMENT
TO:
ALL RECORD HOLDERS AND BENEFICIAL OWNERS OF COMMON STOCK OF THE BABCOCK & WILCOX ENTERPRISES, INC. ("B&W") WHO CURRENTLY OWN B&W COMMON STOCK AND WHO OWNED IT AS OF JULY 22, 2019.

PLEASE READ THIS SUMMARY NOTICE CAREFULLY AND IN ITS ENTIRETY AS YOUR RIGHTS MAY BE AFFECTED BY PROCEEDINGS IN THE LITIGATION.

YOU ARE HEREBY NOTIFIED that the above-captioned consolidated stockholder derivative action (the "Federal Derivative Action"), is being settled on the terms set forth in the Stipulation and Agreement of Settlement dated July 22, 2019 (the "Stipulation"). The Settlement also settles and releases any claims that have been brought or may or could arise out of a derivative action captioned, Pamela Marks v. E. James Ferland, et al. , Case No. 18-CVS-21193 (N.C. Super. Ct.-Mecklenburg Cty.) (the "State Derivative Action") (together with the Federal Derivative Action, the "Actions"). This Summary Notice of Proposed Settlement ("Summary Notice") is provided by order of the United States District Court for the Western District of North Carolina (the "Court").

The Federal Derivative Action alleges claims against each of the Individual Defendants 1 for breach of fiduciary duty and violations of the federal securities laws. The State Derivative
______________________________
1 All capitalized terms that are not otherwise defined shall have the definitions as set forth in the Stipulation.





Action alleges claims against each of the Individual Defendants for breach of fiduciary duty 2 . Pursuant to the terms of the Settlement, B&W agrees to adopt practices, resolutions, and/or amend committee charters and/or the Company's Bylaws within forty-five (45) days of issuance of the Order and Final Judgment to ensure the adoption, implementation, and maintenance of certain corporate governance reforms (the "Reforms"). The Reforms shall be maintained for five (5) years, subject to certain terms and conditions set forth in the Stipulation. The Parties agree that the initiation, prosecution, and settlement of the Actions were primary and significant factors in B&W's adoption of the Reforms. The Parties further agree that the Reforms confer a substantial benefit to B&W as part of the Settlement.
The Defendants also agree for their insurer to pay attorneys' fees and expenses to Plaintiffs' Counsel in the total amount of $1,000,000 (the "Fee and Expense Amount"), subject to approval of the Court. As part of the Settlement, Plaintiffs will each receive a service award of $1,500 to be paid out of the Fee and Expense Amount, subject to the Court's approval. Defendants have denied and continue to deny each and all of the claims and allegations of wrongdoing asserted in the Federal and State Derivative Actions.
On December 16, 2019, at 10:30 a.m., a hearing (the "Settlement Hearing") will be held before Judge Max O. Cogburn, Jr. at the United States District Court for the Western District of North Carolina, 401 W. Trade St, Charlotte, NC 28202 for the purpose of determining whether the Settlement should be approved as fair, reasonable, and adequate and whether the Fee and Expense Amount should be approved. Because this is not a class action, but is a stockholder derivative action brought for the benefit of B&W, except as otherwise provided for in the Stipulation with respect to the named plaintiffs, no Current B&W Stockholder has the right to receive any individual compensation as a result of the Settlement.

This Summary Notice provides a condensed overview of certain provisions of the Stipulation and the full Notice of Proposed Settlement (the "Notice"). It is not a complete statement of the events of the Federal and State Derivative Actions or the terms set forth in the Stipulation. This summary should be read in conjunction with, and is qualified in its entirety by reference to, the text of the Stipulation. For additional information about the claims asserted in the Federal and State Derivative Actions, and the terms of the proposed Settlement, you may inspect the Stipulation and other papers at the Clerk's office in the Court at any time during regular business hours. In addition, copies of the Stipulation and the Notice are available on the Investor Relations section of the Company's website at www.babcock.com/questions. Inquiries about the Federal and State Derivative Actions or the Settlement may be made to: Robbins Arroyo LLP, 5040 Shoreham Place, San Diego, CA 92122; The Brown Law Firm, P.C., 240 Townsend Square, Oyster Bay, NY 11771; and Holzer & Holzer, LLC, 1200 Ashwood Parkway, Suite 410, Atlanta, GA 30338.

You may enter an appearance before the Court, at your own expense, individually or through counsel of your choice. If you want to object at the Settlement Hearing, you must be a Current B&W Stockholder and you must first comply with the procedures for objecting that are set forth in the


_______________________

2 Leslie Kass and Daniel W. Hoehn are not named as defendants in the State Derivative Action.






Stipulation and its accompanying exhibits, including the Notice. Any objection to any aspect of the Settlement must be filed with the Clerk of the Court no later than November 25, 2019 (21 days before the Settlement Hearing) , in accordance with the procedures set forth in the Stipulation and the Notice. Any objection may not exceed 25 pages in length. Any Current B&W Stockholder who fails to object in accordance with such procedures will be bound by the Order and Final Judgment of the Court granting final approval to the Settlement and the releases of claims therein, and shall be deemed to have waived the right to object (including the right to appeal) and forever shall be barred, in this proceeding or in any other proceeding, from raising such objection.

PLEASE DO NOT CONTACT THE COURT OR THE CLERK'S OFFICE REGARDING THIS SUMMARY NOTICE .